Long Term Observational, Prospective, Multicenter Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

Condition:   Hidradenitis Suppurativa Intervention:   Other: secukinumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting

Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials